Looks like Gold doesn't spend all his time on Biocurex after all. He's a very busy beaver lately. The following post is from "Vestor Guy" (Goldseeker), on the RPC message board:
<No approval in China 10-Apr-10 02:52 am
"Under the new guidelines, the SFDA is unlikely to approve the marketing of the DR-70 test kit without the following: approval by the USFDA (obtained July 2008) and sufficient clinical trial data in China. AMDL has engaged Jyton & Emergo Medical Technology, Inc. (Beijing, China), an international regulatory affairs and clinical research consulting group, to assist with the DR-70 test kit clinical trials in China and with filing the SFDA application for the DR-70 test kit. AMDL and Jyton & Emergo have completed a Chinese-language application to support the DR-70 test kit, and we met with the Director of Medical Device Evaluation for the SFDA to define our clinical trial requirements. AMDL will need to perform clinical testing of the DR-70 test kit test for 1,000 patients in China at SFDA approved hospitals. Clinical trials in China are likely to begin in the third quarter of 2009 and we estimate that they will be completed in two years, although we cannot accurately predict when clinical trials will be completed.">
Here's a response from another poster:
<
Re: No approval in China 10-Apr-10 03:08 am China is not the news or in the news. Try again...it's right in front of you. But you won't try...because your history shows you bashing this stock constantly. Nice try !!!>
Like Biocurex this is another company Goldseeker has no finacial interest in. Anyone else other than me see a pattern? And I thought Goldseeker devoted all his time to Biocurex. This proves Goldseeker is a professional.
